Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Capital Expenditures (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Capital Expenditures for 16 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 13.06% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2025, down 2.57% year-over-year, with the annual reading at $6.8 million for FY2025, 2.57% down from the prior year.
  • Capital Expenditures for Q4 2025 was $1.8 million at Lemaitre Vascular, down from $2.3 million in the prior quarter.
  • The five-year high for Capital Expenditures was $2.8 million in Q2 2023, with the low at $460000.0 in Q3 2022.
  • Average Capital Expenditures over 5 years is $1.5 million, with a median of $1.4 million recorded in 2024.
  • The sharpest move saw Capital Expenditures soared 351.13% in 2021, then plummeted 74.64% in 2022.
  • Over 5 years, Capital Expenditures stood at $606000.0 in 2021, then soared by 107.92% to $1.3 million in 2022, then grew by 1.51% to $1.3 million in 2023, then soared by 59.81% to $2.0 million in 2024, then decreased by 13.06% to $1.8 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $1.8 million, $2.3 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.